Diabetes decisions — 2025

The Board remanded the claim for service connection of coronary artery disease (CAD) to obtain outstanding private treatment records and schedule a VA examination.

The Board remanded the Veteran's claims for service connection for diabetes mellitus, type II and hypertension due to exposure to herbicide agents and/or dioxides. The Board found that there has not been substantial compliance with previous remand directives and additional development is necessary.

The Board denied service connection for diabetes mellitus type II based on the Veteran's claimed exposure to herbicide agents in Thailand and Guam.

The Board denied the veteran's claims for earlier effective dates and higher disability ratings, finding that the evidence did not support a more favorable outcome.

The Board granted service connection for diabetes mellitus and obstructive sleep apnea (OSA) as proximately caused by the Veteran's service-connected disabilities.

The Board denied an earlier effective date for the award of service connection for type II diabetes mellitus, as it was granted under a liberalizing law effective from August 10, 2022.

The Board granted service connection for tinnitus and remanded the claims for an acquired psychiatric disability, a sleep disorder, type two diabetes mellitus, cardiovascular disease, vertigo, hypertension, migraine headaches, arthritis of various joints, and kidney disease.

The Board remands the claim for service connection of diabetes mellitus, type II, to obtain a new medical opinion that addresses the Veteran's assertions and considers all potential toxic exposures during his service in Southwest Asia.

The Board remands the service connection claims for coronary heart disease, diabetes, and knee degenerative disease due to a pre-decisional duty to assist error.

The Board denied service connection for diabetes mellitus, acid reflux, atrial fibrillation, and a digestive tract disorder. A compensable rating for perforated ear drum was also denied.

The Board granted an increased initial rating of 70 percent for the acquired psychiatric disorder prior to April 30, 2018, and denied a higher rating. The Veteran's chronic headaches were granted a 30 percent rating prior to September 1, 2016, but not beyond that date.

The appeal for service connection for bone cancer, diabetes mellitus type II, heart attack/open heart surgery, and stage 4 prostate cancer was dismissed due to the Veteran's death.

The Board denied increased ratings for diabetes mellitus, type II and diabetic peripheral neuropathy of the bilateral lower extremities, but granted a 20 percent rating for diabetic peripheral neuropathy of both legs as of February 10, 2022.

The Board denied service connection for diabetes mellitus type II but granted service connection for tinnitus.

The Board denied earlier effective dates for the awards of separate 20 percent ratings for right and left lower extremity femoral nerve diabetic peripheral neuropathy, as well as a rating in excess of 20 percent for diabetes mellitus.

The Board denied service connection for all the claimed conditions as there was no evidence to support a causal relationship between any of the claimed conditions and the Veteran's active military service.

The Board denied service connection for a liver disorder, diabetes, high blood pressure, kidney disorder, back disability, left knee disability, and right knee disability. Some claims were remanded.

Service connection for COPD secondary to asbestos exposure is granted, effective from April 7, 2014. Other issues are remanded.

The Board remanded the veteran's claims for service connection for diabetes mellitus and an initial rating in excess of 10 percent for sinusitis. The decision was based on the need to obtain outstanding private treatment records and conduct a new VA examination.

The Board has remanded the case for further development to address the Veteran's reported exposure to herbicides and common garrison exposures, including fuel, oil, lubricants, and asbestos. The VA will obtain updated medical records, provide a TERA and ILER update, and conduct an examination to determine if the Veteran's diabetes mellitus is related to his service.